BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7533365)

  • 1. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
    Loss M; Winkler M; Schneider A; Brinkmann C; Manns M; Ringe B; Pichlmayr R
    Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy.
    Loss M; Winkler M; Schneider A; Oldhafer K; Manns MP; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):1006-7. PubMed ID: 8623210
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study.
    Mor E; Facklam D; Hasse J; Sheiner P; Emre S; Schwartz M; Miller C
    Transplant Proc; 1995 Feb; 27(1):1126. PubMed ID: 7533363
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
    Abouljoud MS; Levy MF; Klintmalm GB
    Transplant Proc; 1995 Feb; 27(1):1121-3. PubMed ID: 7533360
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA; Gimson AE; Gibbs P; Alexander GJ
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
    Manzarbeitia C; Reich DJ; Rothstein KD; Braitman LE; Levin S; Munoz SJ
    Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial.
    Steinmüller TM; Gräf KJ; Schleicher J; Leder K; Bechstein WO; Mueller AR; Dette K; Schulz E; Neuhaus P
    Transplantation; 1994 Sep; 58(6):669-74. PubMed ID: 7524203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile.
    Woodside KJ; Nichols SD; Hunter GC; Gugliuzza KK; Daller JA
    Transplant Proc; 2005 May; 37(4):1877-9. PubMed ID: 15919491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation.
    Andrews WS; Sommerauer J; Conlin C; Moore P
    Transplant Proc; 1996 Apr; 28(2):897-8. PubMed ID: 8623452
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506.
    Krentz AJ; Cramb R; Dousset B; Mayer D; McMaster P; Buckels J; Smith JM; Nattrass M
    J Lab Clin Med; 1994 Sep; 124(3):381-5. PubMed ID: 7521895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
    Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
    Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
    Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.
    Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP
    Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation.
    Wierzbicka A; Pawłowska J; Socha P; Jankowska I; Skorupa E; Teisseyre M; Ismail H; Czubkowski P; Socha J
    Transplant Proc; 2007 Jun; 39(5):1523-5. PubMed ID: 17580179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclosporine vs FK 506 on glucose metabolism.
    Steinmueller T; Konrad T; Jonas S; Tullius S; Bechstein WO; Mueller A; Platz KP; Neumann U; Vicini P; Toffolo G; Cobelli C; Usadel KH; Neuhaus P
    Transplant Proc; 1999; 31(1-2):1129-30. PubMed ID: 10083504
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression.
    Castelao AM; Barberá MJ; Blanco A; Fiol C; Griñó JM; Bover J; GilVernet S; Andrés E; Serón D; Castiñeiras MJ
    Transplant Proc; 1992 Feb; 24(1):96-8. PubMed ID: 1539356
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
    Pohanka E; Margreiter R; Sparacino V; Sperschneider H;
    Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.